2nd Quarter - Report

BIOGEN for BIOGEN

Firm
Client
Income
—
Expenses
$240,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

LobbyistCovered position, as disclosed
ADAM GLUCK Staff, Senate HELP Committe
KATHLEEN TREGONING Staff, House Ways and Means Committee

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Taxation/Internal Revenue Code TAX

Advocacy related to corporate tax policies, including repatriation, "deferral", "check the box", transfer pricing, and R&D credit.

LobbyistCovered position, as disclosed
ADAM GLUCK Staff, Senate HELP Committee
KATHLEEN TREGONING Staff, House Ways and Means Committee

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

Advocacy for appropriate reimbursement terms and payment rates for biologics under the Medicare and Medicaid programs.

LobbyistCovered position, as disclosed
ADAM GLUCK Staff, Senate HELP Committee
KATHLEEN TREGONING Staff, House Ways and Means Committee

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Copyright/Patent/Trademark CPT

Patent Reform -- S. 515 and HR 1260 -- Support for modernizing the patent system while ensuring the ongoing strength and value of intellectual property for biotechnology, with a specific focus on damages provisions, inequitable conduct, and post-grant/second window. Opposition to prohibition of patent settlements.

LobbyistCovered position, as disclosed
ADAM GLUCK Staff, Senate HELP Committee
KATHLEEN TREGONING Staff, House Ways and Means Committee

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1260 (111th), S. 515 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.